ArticleFrontiers in medicine2026
A prediction model for urological tumor metastasis using liquid biopsy-derived biomarkers.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To construct and validate a prediction model for tumor metastasis in patients with urological tumors based on liquid biopsy biomarkers and clinical characteristics, to facilitate early clinical identification of metastasis risk and formulation of individualized diagnosis and treatment plans. Methods: A total of 360 patients with urological tumors admitted to our hospital from January 2021 to December 2024 were retrospectively included. They were randomly divided into a training set ( Results: There was no significant difference in baseline data between the training set and the validation set ( Conclusion: The random forest model constructed based on liquid biopsy predictive indicators can effectively predict tumor metastasis in patients with urological tumors. Neutrophil count, platelet count, and white blood cell count are key prediction indicators for urological tumor metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.